Bank of America reiterated its Buy rating on CVS Caremark (NYSE:
CVS). At the same time, the rating agency left its price target on the company's stock unchanged at $46. On Tuesday, CVS closed the day at $33.23.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
